Evidence map›Paper›PMID 33852026›Full record

ReviewPediatric radiology2022

Magnetic resonance imaging of pediatric liver tumors.

Anil K Vasireddi, Madeline E Leo, Judy H Squires

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. European journal of nuclear medicine and molecular imaging · 2022
    Article
  8. Article
  9. [Polyaspartic acid grafted dopamine polymer chelated FeSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2022
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anil K VasireddiDepartment of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Madeline E LeoDepartment of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Judy H SquiresDepartment of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Judy.Squires@chp.edu.ORCID http://orcid.org/0000-0002-1237-3504

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver tumors in children can be benign or malignant. Although several clinical factors are important in the evaluation of these lesions, MRI is particularly important for lesion characterization and tumor staging. In children, use of a hepatobiliary contrast agent is recommended to evaluate a known or suspected liver lesion. In this review, we discuss the most common benign and malignant pediatric liver tumors, including vascular tumors, mesenchymal hamartoma, focal nodular hyperplasia, hepatocellular adenoma, hepatoblastoma, hepatocellular carcinoma, fibrolamellar hepatocellular carcinoma, undifferentiated embryonal sarcoma and metastases, with emphasis on relevant clinical information and imaging appearance at MRI using hepatobiliary agents.

Indexed as

Adenoma, Liver CellCarcinoma, HepatocellularFocal Nodular HyperplasiaLiver NeoplasmsChildContrast MediaHumansLiverMagnetic Resonance ImagingContrast MediaChildrenGadoxetate disodiumHepatobiliary contrast agentLiverMagnetic resonance imagingTumor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.